VF
DRUG

Virtu Financial’s Bright Minds Biosciences DRUG Stock Holding History

Virtu Financial’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,129
Closed -$228K – 1758
2026
Q1 		$228K Buy
3,129
+232
+8% +$18.7K 0.01% 958
2025
Q4 		$226K Buy
+2,897
New +$194K 0.01% 969
2024
Q1 		– Sell
-10,399
Closed -$15K – 1558
2023
Q4 		$15K Sell
10,399
-2,705
-21% -$3.86K ﹤0.01% 1359
2023
Q3 		$21K Buy
+13,104
New +$34.9K ﹤0.01% 1008
2023
Q1 		– Sell
-7,743
Closed -$29K – 1641
2022
Q4 		$29K Buy
+7,743
New +$38.3K ﹤0.01% 1186
2022
Q2 		– Sell
-2,912
Closed -$22K – 1691
2022
Q1 		$22K Buy
+2,912
New +$32.7K ﹤0.01% 1284

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Virtu Financial's DRUG Position: Q2 2026 in Review

Virtu Financial sold out of Bright Minds Biosciences (DRUG) in Q2 2026, closing a stake of 3,129 shares — an estimated $228K sold.

Virtu Financial first reported a position in DRUG in Q1 2022 and held it in 6 quarters. The position peaked at $228K in Q1 2026. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Virtu Financial reported no remaining Bright Minds Biosciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 3,129 Bright Minds Biosciences shares in Q2 2026, an estimated $228K.
  • Virtu Financial first reported a position in Bright Minds Biosciences in Q1 2022 and held it in 6 quarters.
  • Virtu Financial's Bright Minds Biosciences position peaked at $228K in Q1 2026.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.